Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific
Tadahisa Shono1, Philip J Tofilon, Timothy S Schaefer
1Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.
Abstract:
Therapeutic replacement of the p53 gene using an adenovirus vector (Ad-p53) may be an effective alternative to conventional therapies for the treatment of glioma. We have previously demonstrated that the introduction of Ad-p53 into glioma cells containing mutant p53 induces apoptosis, whereas glioma cells containing wild-type p53 are resistant. However, Ad-p53 will enhance the radiosensitivity of wild-type p53 glioma cells by increasing their tendency for apoptosis. The mechanism underlying these different responses to Ad-p53 has not been elucidated to date. Because phosphorylation of p53 at serines 15, 20, and 392 may play a role in regulating p53-mediated apoptotic activity, we determined the phosphorylation status of exogenous p53 in mutant and wild-type gliomas after Ad-p53 transfer. Monolayer cultures of glioma cell lines expressing mutant p53 (U251 and U373) or wild-type p53 (U87 and D54) were infected with Ad-p53 and analyzed by Western blotting. High levels of exogenous p53 were detected in both cell lines after Ad-p53 transfer. However, only apoptotic mutant p53 cells expressed high levels of phospho-Ser15-p53 and phospho-Ser20-p53. The levels of phospho-Ser15-p53 and phospho-Ser20-p53 were very low in wild-type p53 cells after Ad-p53 infection alone. When wild-type p53 glioma cells were exposed to radiation after Ad-p53 infection, phospho-Ser15-p53 and phospho-Ser20-p53 were detected at high levels, and the cells subsequently underwent apoptosis; no change in serine 392 was detected. The induction of apoptosis and the expression of phospho-Ser15 and phospho-Ser20 in these cells were also enhanced by the combination of Ad-p53 and other DNA-damaging agents such as cisplatin and bichloroethyl nitrosourea. Furthermore, the expression of phospho-Ser15-p53 and phospho-Ser20-p53 correlated with the amount of apoptosis; the apoptotic activity of p53 in glioma cells was partially inhibited by a mutation of p53 at serine 15. These results suggest that phosphorylation of p53 at serine 15 and serine 20 is critical for apoptosis induction in p53 gene therapy for gliomas.
Insights
Adenovirus-mediated p53 gene therapy (Ad-p53) shows promise for glioma treatment. Phosphorylation of p53 at serines 15 and 20 is crucial for inducing apoptosis in glioma cells, enhancing Ad-p53 therapy effectiveness.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Glioma treatment faces challenges with conventional therapies.
- Adenovirus-mediated p53 gene therapy (Ad-p53) is a potential alternative.
- Differential responses of mutant vs. wild-type p53 glioma cells to Ad-p53 require mechanistic understanding.
Purpose of the Study:
- To investigate the role of p53 phosphorylation in Ad-p53-mediated apoptosis in glioma cells.
- To elucidate the mechanism behind differential Ad-p53 responses in mutant and wild-type p53 glioma cells.
- To assess the impact of p53 phosphorylation at serines 15, 20, and 392 on Ad-p53 therapy outcomes.
Main Methods:
- Utilized glioma cell lines with mutant (U251, U373) and wild-type (U87, D54) p53.
- Infected cells with Ad-p53 and analyzed exogenous p53 expression via Western blotting.
- Assessed phosphorylation status of p53 at serines 15, 20, and 392.
- Investigated apoptosis induction in response to Ad-p53 alone, combined with radiation, cisplatin, or BCNU.
Main Results:
- High levels of exogenous p53 were detected in all infected glioma cells.
- Apoptotic mutant p53 cells showed high levels of phospho-Ser15-p53 and phospho-Ser20-p53.
- Wild-type p53 cells had low levels of phospho-p53 after Ad-p53 infection alone.
- Combined Ad-p53 and radiation/chemotherapy significantly increased phospho-Ser15/20-p53 and apoptosis in wild-type cells.
- Phosphorylation at Ser15 and Ser20 correlated with apoptosis levels; Ser15 mutation partially inhibited p53 apoptotic activity.
Conclusions:
- Phosphorylation of p53 at serine 15 and serine 20 is critical for Ad-p53-induced apoptosis in glioma.
- This phosphorylation mechanism explains differential responses and enhances therapeutic efficacy of Ad-p53 in glioma.
- Targeting p53 phosphorylation may optimize gene therapy strategies for glioma treatment.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Abnormal Proliferation
Apoptosis
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
